Company information:
Redx Immunology Limited (No: 09000503)
Address: BLOCK 33 MERESIDE, ALDERLEY PARK, MACCLESFIELD, SK10 4TG, ENGLAND
Status: Active
Incorporated: 16-Apr-2014
Accounts Next Due: 30-Jun-2025
Next Confirmation Statement Due: 30-Apr-2025
Industry Class: 72110 - Research and experimental development on biotechnology
Current Director: LISA MARY WHEWELL ANSON ( DOB: Apr-1968 From: Feb-2020 )
Current Director: LISA MARY WHEWELL ANSON ( DOB: Apr-1968 From: Feb-2020 )
Current Director: JAMES ROBERT MEAD ( DOB: May-1977 From: Mar-2019 )
Current Secretary: CLAIRE PENELOPE SOLK ( From: Sep-2022 )
Resigned Director: DOMINIC NICHOLAS JACKSON ( DOB: Jan-1981 From: Feb-2018 To: Jan-2019 )
Resigned Director: DEREK LINDSAY ( DOB: Jul-1961 From: Aug-2015 To: May-2016 )
Resigned Director: NORMAN MOLYNEUX ( DOB: Mar-1956 From: Apr-2014 To: Aug-2015 )
Resigned Director: NEIL DAVID MURRAY ( DOB: Aug-1963 From: Aug-2015 To: Nov-2017 )
Resigned Director: IAIN GLADSTONE ROSS ( DOB: Jan-1954 From: Nov-2017 To: May-2021 )
Resigned Director: PHILIP JOHN TOTTEY ( DOB: Aug-1961 From: Aug-2015 To: Sep-2016 )
Persons of Significant Control:
Redx Pharma Plc, Block 33 Mereside, Alderley Park, Macclesfield, Merseyside, SK10 4TG, United Kingdom: Ownership of shares – 75% or more, Ownership of voting rights - 75% or more, Right to appoint and remove directors (Notified: 2016-04-06)
Dr Neil David Murray, Block 33 Mereside, Alderley Park, Macclesfield, SK10 4TG, England: Has significant influence or control (Notified: 2016-09-30, Ceased: 2017-11-03)